---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-041847"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T01:56:28.893131+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oramed CFO David Silberman resigns, effective July 12, 2024

## Summary
- David Silberman stepped down as CFO, Treasurer and Secretary for personal reasons.
- His resignation is effective July 12, 2024, with a transition period until then.
- Company has initiated a search for a new CFO to replace Silberman.
- The departure is voluntary and not due to any disagreement with Oramed.

## SEC filing metadata
- accession: 0001213900-24-041847
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024041847/0001213900-24-041847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024041847/ea0205772-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-041847
- JSON: https://secwatch.observer/filing/0001213900-24-041847.json
- Plain text: https://secwatch.observer/filing/0001213900-24-041847.txt

## Key facts
- Executive change
  David Silberman resigned as Chief Financial Officer, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC..
  - Action: resigned
  - Role: Chief Financial Officer, Treasurer and Secretary
  source text: On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390024041847/0001213900-24-041847-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.